Egetis Therapeutics — Major Shareholding Notification 2020

Nov 27, 2020

Issuer Egetis Therapeutics AB (publ)

Holder

Fjärde AP-fonden

Instrument

Instrument	Aktie
Before the transaction
Shares	3,238,427
Voting rights	3,238,427
Transaction
Date	26/11/2020
Limit for number of shares 5 %
Limit for number of votes	5 %

After the transaction

Quantity

Shares	14,311,300
Directly held voting rights 14,311,300
Indirectly held voting rights 0

Percentage

Directly held shares 8.67 % Directly held voting rights 8.67 % Indirectly held voting rights 0 %

Resulting distribution of total

holdings
Shares	Percentage of voting rights:	Number of underlying shares:
	8.67 %	14,311,300
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	8.67 %	14,311,300
Group total holdings

Voting rights 14,311,300

Percentage of voting rights 8.67

Notes (other relevant informations according to law)

Flaggning baserad på det nya antalet utestående aktier (165,068,560), efter att alla emissioner registrerats.

Published

27/11/2020 09:18

Contact

Name Jannis Kitsakis Phone 070-6038023 Email jannis.kitsakis@ap4.se

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25